OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GNFT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Genfit SA (GNFT) Earnings Date & Reports

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GNFT is expected to report earnings to rise 81.45% to -36 cents per share on April 09

Q4'25

Est.

$-0.36

Q2'25

Missed

by $0.31

Q4'24

Beat

by $0.02

Q2'24

Beat

by $0.25

The last earnings report on September 22 showed earnings per share of -20 cents, missing the estimate of 11 cents. With 7.62K shares outstanding, the current market capitalization sits at 213.49M.

View a ticker or compare two or three

Compare

GNFT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GNFT
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GNFT showed earnings on September 22, 2025. You can read more about the earnings report here.

View AI-Driven Trading for GNFT

A.I. Advisor

published General Information

General Information

a developer of biopharmaceutical products for the treatment of cardio metabolic and neurodegenerative diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Parc Eurasante

Phone

+33 320164000

Employees

148

Web

https://www.genfit.com